University of Michigan Comprehensive Cancer Center
Translates scientific discoveries into clinical advances
Acceptance Speech
Maha H. Hussain, MB ChB, is the Cis Maisel Professor of Oncology and a
professor of medicine and urology at the University of Michigan. She serves
as the associate director for Clinical Research and co-leader of the Prostate
Cancer/GU Oncology Program at the University of Michigan Comprehensive Cancer Center (UMCCC). Her work and accomplishments include:
Contributed to research that led to the FDA approval of docetaxel for
the treatment of men with advanced prostate cancer
As lead investigator, evaluated optimal schedules of androgen deprivation
therapy for patients with newly diagnosted metastatic prostate
cancer through an international collaborative trial
Pioneered novel clinical trials in bladder and prostate cancer
Guided national research through various leadership positions, including
as co-chair of the Prostate Cancer subcommittee of SWOG GU committee,
as a member and 2013 chair of the Integration Panel (IP) of
US Army Medical Research and Materiel Command Prostate Cancer
Research Program, and as a member of the NCI-Cancer Biomarker
Study Section and the NCI´s prostate cancer task force
Serves as an FDA consultant and has served as a member and chair
of the FDA Oncology Drug Advisory Committee
Served/serves on the editorial boards of several national and
international specialty publications, including the Journal of ClinicalOncology and the American Journal of Translational Research
Honored with the University of Michigan Medical School League of
Research Excellence award and the 2012 Clinical & Health Services
Research award